Correction to: Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCs Yingli ZhuThibaut BurgCatherine Verfaillie Correction Open access 13 June 2024 Article: 99
Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus Barbara SárkányCsaba DávidTim J. Viney Original Paper Open access 11 June 2024 Article: 98
Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer’s disease Feng GaoMengguo ZhangFor CANDI Consortium Original Paper 10 June 2024 Article: 97
The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease Sriram BalusuBart De Strooper Review Open access 09 June 2024 Article: 96
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations Konstantin OkonechnikovDaniel SchrimpfAndrey Korshunov Original Paper 07 June 2024 Article: 95
Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer’s disease pathology progression Kunie AndoFahri KüçükaliBrain Bank NeuroCEB Neuropathology Network Original Paper Open access 04 June 2024 Article: 94
Alternatively spliced ELAVL3 cryptic exon 4a causes ELAVL3 downregulation in ALS TDP-43 proteinopathy Isabel CostantinoAlex MengJohn Ravits Correspondence Open access 30 May 2024 Article: 93
Neuropathological findings in Down syndrome, Alzheimer’s disease and control patients with and without SARS-COV-2: preliminary findings Ann-Charlotte E. GranholmElisabet EnglundElliott J. Mufson Original Paper Open access 27 May 2024 Article: 92
The influence of APOEε4 on the pTau interactome in sporadic Alzheimer’s disease Manon ThierryJackeline PonceThomas Wisniewski Original Paper Open access 21 May 2024 Article: 91
Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions Alyse de BoerAletta M. R. van den BoschInge R. Holtman Original Paper Open access 21 May 2024 Article: 90
Transmission experiments verify sporadic V2 prion in a patient with E200K mutation Hitaru KishidaAtsushi KobayashiTetsuyuki Kitamoto Correspondence Open access 20 May 2024 Article: 89
From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson’s disease. Scientific commentary on: “Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease” Nourhan SheblMohamed Salama Correspondence 18 May 2024 Article: 88
Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry Michael J. EllisChristiana LekkaM. Irina Stefana Original Paper Open access 18 May 2024 Article: 87
Tau filaments with the chronic traumatic encephalopathy fold in a case of vacuolar tauopathy with VCP mutation D395G Chao QiRyota KobayashiMasato Hasegawa Original Paper 17 May 2024 Article: 86
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors Andrew L. LinVasilisa A. RudnevaViviane Tabar Original Paper Open access 17 May 2024 Article: 85
Aberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC astrocytes Nicolas LeventouxSatoru MorimotoHideyuki Okano Original Paper 15 May 2024 Article: 84
Anaplastic histology and distinct molecular features in a small series of spinal cord ependymomas Ulrich SchüllerAntonia GockeJulia E. Neumann Correspondence Open access 12 May 2024 Article: 83
Physiological aging and inflammation-induced cellular senescence may contribute to oligodendroglial dysfunction in MS Farina WindenerLaureen GrewingTanja Kuhlmann Original Paper Open access 09 May 2024 Article: 82
The shoulders we keep standing on: remembering Otto Marburg, a big brain in neurology and multiple sclerosis, at 150 Klaus SchmiererHans Lassmann Editorial 08 May 2024 Article: 81
Impaired GABAergic regulation and developmental immaturity in interneurons derived from the medial ganglionic eminence in the tuberous sclerosis complex Mirte ScheperFrederik N. F. SørensenEleonora Aronica Original Paper Open access 07 May 2024 Article: 80
Sex differences in the extent of acute axonal pathologies after experimental concussion Hailong SongAlexandra TomasevichDouglas H. Smith Original Paper Open access 05 May 2024 Article: 79
Characterisation of premature cell senescence in Alzheimer’s disease using single nuclear transcriptomics Nurun N. FancyAmy M. SmithPaul M. Matthews Original Paper Open access 02 May 2024 Article: 78
Viral entry and translation in brain endothelia provoke influenza-associated encephalopathy Shihoko Kimura-OhbaMieko KitamuraTomonori Kimura Original Paper Open access 30 April 2024 Article: 77
Stage-dependent immunity orchestrates AQP4 antibody-guided NMOSD pathology: a role for netting neutrophils with resident memory T cells in situ Akihiro NakajimaFumihiro YanagimuraIzumi Kawachi Original Paper 24 April 2024 Article: 76
BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair Anastasia GeladarisSebastian TorkeMartin S. Weber Original Paper Open access 24 April 2024 Article: 75
Nanopore sequencing from formalin-fixed paraffin-embedded specimens for copy-number profiling and methylation-based CNS tumor classification Ann-Kristin AfflerbachAnne AlbersChristian Thomas Correspondence Open access 20 April 2024 Article: 74
Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion Evan UdineMariely DeJesus-HernandezMarka van Blitterswijk Original Paper Open access 19 April 2024 Article: 73
Characterization of NEB pathogenic variants in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects Esmat KarimiJochen GohlkeHenk Granzier Original Paper Open access 18 April 2024 Article: 72
Histologic correlates of “Choroidal abnormalities” in Neurofibromatosis type 1 (NF1) Anat O. Stemmer-RachamimovLiana KozannoJoseph F. 3rd Rizzo Original Paper 12 April 2024 Article: 71
Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease Prabesh BhattaraiTamil Iniyan GunasekaranBadri N. Vardarajan Original Paper Open access 10 April 2024 Article: 70
Regulated cell death and its role in Alzheimer’s disease and amyotrophic lateral sclerosis Dietmar Rudolf ThalKlara GaworSebastiaan Moonen Review 07 April 2024 Article: 69
Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype Farshad NassiriAndrew AjisebutuGelareh Zadeh Original Paper 07 April 2024 Article: 68
Altered TFEB subcellular localization in nigral neurons of subjects with incidental, sporadic and GBA-related Lewy body diseases Tim E. MoorsMartino L. MorellaWilma D. J. van de Berg Original Paper Open access 06 April 2024 Article: 67
Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer’s disease and related dementias Methasit Jaisa-aadClara Muñoz-CastroAlberto Serrano-Pozo Original Paper Open access 03 April 2024 Article: 66
Landscape of brain myeloid cell transcriptome along the spatiotemporal progression of Alzheimer’s disease reveals distinct sequential responses to Aβ and tau Astrid WachterMaya E. WoodburyBradley T. Hyman Original Paper Open access 01 April 2024 Article: 65
Microglial phagolysosome dysfunction and altered neural communication amplify phenotypic severity in Prader-Willi Syndrome with larger deletion Felipe Correa-da-SilvaJenny CarterChun-Xia Yi Original Paper Open access 31 March 2024 Article: 64
Correction to: MET receptor serves as a promising target in melanoma brain metastases Torben RedmerElisa SchumannJosefine Radke Correction Open access 27 March 2024 Article: 63
Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice Tuancheng FengHuan DuFenghua Hu Original Paper 25 March 2024 Article: 62
TMEM106B coding variant is protective and deletion detrimental in a mouse model of tauopathy George A. Edwards IIICaleb A. WoodJoanna L. Jankowsky Original Paper 25 March 2024 Article: 61
A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin Carolina M. CasseliniHenri K. ParsonNigel A. Calcutt Original Paper 25 March 2024 Article: 60
Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models Yvonne BouterJose Socrates Lopez NoguerolaThomas A. Bayer Correction 25 March 2024 Article: 59
Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies Carolina Maldonado-DíazSatomi HiyaTimothy E. Richardson Original Paper Open access 23 March 2024 Article: 58
Gene transcript fusions are associated with clinical outcomes and molecular groups of meningiomas Naomi ZakimiMinh P. NguyenDavid R. Raleigh Correspondence Open access 20 March 2024 Article: 57
Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia Christine MarquesAaron HeldBrian J. Wainger Original Paper Open access 13 March 2024 Article: 56
MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons Hong XuQi QiuVirginia M.-Y. Lee Original Paper Open access 12 March 2024 Article: 55
Role of GBA variants in Lewy body disease neuropathology Ronald L. WaltonShunsuke KogaMichael G. Heckman Original Paper 12 March 2024 Article: 54
Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophy Andreas RoosLinda-Isabell SchmittTim Hagenacker Original Paper Open access 12 March 2024 Article: 53
Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease Jarod RutledgeBenoit LehallierKathleen L. Poston Original Paper Open access 11 March 2024 Article: 52
The prevalence and topography of spinal cord demyelination in multiple sclerosis: a retrospective study Alex D. WaldmanCecilia CataniaGabriele C. DeLuca Original Paper Open access 09 March 2024 Article: 51
RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS Holly SpenceFergal M. WaldronJenna M. Gregory Original Paper Open access 05 March 2024 Article: 50